Piper Sandler lowered Colgate-Palmolive's price target to $95 due to weak North American demand and rising competition. The company is responding by focusing on premium oral care innovations, expanding the Fabuloso line, increasing advertising, and considering selling some personal care brands like Softsoap and Irish Spring. Despite challenges, the new target implies an 8.6% upside from the current stock price, signaling cautious optimism for recovery. This strategic shift aims to strengthen core, higher-growth areas amid a tough market environment.
Colgate-Palmolive's strategic shift comes as the stock trades at $86.55 on Pluang, down 1.05% as of Sep 21, 2026 20:44 WIB. The company’s market cap stands at $69.73 billion, with a dividend yield of 2.42%, reflecting steady investor interest despite recent challenges. The stock remains below its 52-week high of $99.14, indicating room for potential recovery aligned with the cautious optimism noted by analysts.
